NCT01935102View on ClinicalTrials.gov

Polymorphism Interaction to Predict Bevacizumab Efficacy

CompletedOBSERVATIONAL
Enrollment

169

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2014

Conditions
Metastatic Breast Cancer
Trial Locations (1)

56125

Department of Clinical and Experimental Medicine, University of Pisa, Pisa

All Listed Sponsors
lead

University of Pisa

OTHER

NCT01935102 - Polymorphism Interaction to Predict Bevacizumab Efficacy | Biotech Hunter | Biotech Hunter